Anti-psychotic medication linked to adverse change in brain structure
Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning.... Read More...
antipsychotics
Early treatment of schizophrenia may not slow disease progression
Typical interventions for schizophrenia do not improve long-term outcomes, even when administered early, a new study reports.... Read More...
How CBD takes effect in the brains of people with psychosis
During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period.... Read More...
Antipsychotics associated with increased risk of head & brain injuries in persons with Alzheimer’s disease
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.... Read More...
Long-term medication for schizophrenia is safe
Long-term antipsychotic use does not increase the risk of physical morbidity leading to hospitalization.... Read More...
Antipsychotic medications linked to brain injuries in individuals with Alzheimer’s disease
People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.... Read More...
Early warning signs of eating disorder revealed
A new study reveals several biomarkers for eating disorders that are apparent two years prior to diagnosis. ... Read More...
Some Drug Combinations More Effective Than Others For Patients with Schizophrenia
A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic.... Read More...
Weight Gain Receptor Linked to Antipsychotic Drug
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.... Read More...
Cannabis Compound Could Unlock New Cognitive Treatment for Schizophrenia
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.... Read More...
Gene Links Risk of Psychiatric Disease to Reduced Synapse Numbers
According to researchers, a mutation in a gene associated with brain development may dispose people to various psychiatric illnesses as it reduces synapse numbers. Lithium may help to restore some of the synapses.... Read More...
Dopamine Receptor Blockage Could Be Cause For Side Effects of Some Antipsychotics
Researchers report a blockade of D2 receptors in interneurons can increase acetylcholine signaling above threshold on neighboring neurons, resulting in motor abnormalities.... Read More...